Core Viewpoint - The establishment of the "Shenzhen University-Ningbo Enzyme Bioengineering Co., Ltd. Joint Laboratory for Computational Protein" marks a significant collaboration aimed at advancing AI-driven synthetic biology research and its industrial applications in pharmaceuticals, energy, and agriculture [1][4][6]. Group 1: Joint Laboratory Focus - The joint laboratory will focus on AI-driven synthetic biology research, emphasizing protein design and optimization, high-performance industrial enzyme development, and the application of these technologies in various industries [4][5]. - Key research directions include computational protein design, computer simulation and intelligent optimization of biosynthetic pathways, and talent cultivation in AI-integrated enzyme engineering [5][6]. Group 2: Industry Impact - The introduction of AI technology is expected to revolutionize traditional research methods in protein design, metabolic engineering, and biosynthesis, aiming to create a programmable and scalable intelligent bio-manufacturing platform [6]. - The collaboration is seen as a model for industry-academia cooperation, leveraging the research strengths of Shenzhen University and the industrial capabilities of Ningbo Enzyme Bioengineering to promote practical applications of synthetic biology [6][7]. Group 3: Company Background - Shenzhen University, established as a new research-oriented institution in 2024, focuses on foundational and cutting-edge scientific research and the cultivation of innovative talents [6][7]. - Ningbo Enzyme Bioengineering Co., Ltd. is a leading synthetic biology company in China, possessing proprietary technologies in protein design and enzyme engineering, with capabilities spanning from laboratory research to industrial production [7]. Group 4: Future Prospects - The collaboration signifies a new phase in AI-driven bio-manufacturing, contributing to the high-quality development of China's bio-economy [8].

【DT新材料】 获悉，8月18日， 圣泉集团 发布半年报 ，20 25 年上半年，公司实现营业收入53.51 亿元，同比增长15.67%；实现归属于上市公司 股东 的净利润 5.01 亿元，同比增长 51.19%。报告期末，总资产 162.80 亿元，负债总额 58.05 亿元，资产负债率 35.65%。 | | | | 早V: 儿川州: 人民IJ | | --- | --- | --- | --- | | 主要会计数据 | 本报告期 | 上年同期 | 本报告期比上年 | | | (1-6月) | | 同期增减(%) | | 营业收入 | 5,350,722,861.01 | 4,625,811,646.28 | 15.67 | | 利润总额 | 595,653,685.35 | 403.446.806.33 | 47.64 | | 归属于上市公司股东的净利润 | 500.938.476.44 | 331,323,025.19 | 51.19 | | 归属于上市公司股东的扣除非经常性 损益的净利润 | 480.890.523.68 | 318,201,447.50 | 51.13 | | 经营活动产生的现金流 ...

Core Viewpoint - The article highlights the participation of Huo Tong Instruments at the SynBioCon 2025, emphasizing its leadership in high-end reaction kettle and customized reaction synthesis equipment in China [2][21]. Company Overview - Huo Tong Instruments is headquartered in Shanghai, China, with branches in Hefei, Beijing, Guangzhou, and Taiyuan. The company possesses multiple technical patents and has extensive experience in providing complete solutions from design to manufacturing [5]. - The company integrates research and development, production, and sales, supported by a team of experienced technical personnel and professional after-sales service [5]. Product Summary - **100L Polylactic Acid Reaction Device**: A continuous flow reaction device characterized by continuous feeding, reaction, and discharging, offering high mass and heat transfer efficiency, stability, and safety [6]. - **Resin Synthesis Device**: Features dual gas inlets, high-quality flow meters for accurate measurement, and a deep-cooling reaction kettle with a design temperature of -120°C, along with a user-friendly touchscreen control system [9]. - **Esterification and Polycondensation Reaction Device**: Customizable according to client needs, including high vacuum and high-temperature discharge capabilities [11]. - **Dynamic Tubular Reactor**: Designed for high shear dispersion with a dual heat exchange structure, offering a design pressure of 0-2 MPa and temperature range of -15 to 200°C [14]. - **Intelligent Continuous Flow Platform**: A self-developed system centered around micro-reactors, capable of an annual production capacity of approximately 50 tons [17]. Event Details - The SynBioCon 2025 will take place from August 20-22, 2025, in Ningbo, Zhejiang, focusing on AI and bio-manufacturing, green chemistry, new materials, future food, and agriculture [21]. - The event will include various activities such as a youth forum, high-level discussions, and a closed-door seminar on the "2025 AI Empowering Bio-Manufacturing Industry Innovation Development Blue Book" [21][22][23].

Core Viewpoint - The integration of AI in the biomanufacturing industry is gaining significant attention, driven by national policies promoting automation and intelligence in the sector, alongside the introduction of AI by major biomanufacturing companies, with some even pursuing IPOs [2]. Group 1: AI Applications in Biomanufacturing - The Fourth Synthetic Biology and Green Biomanufacturing Conference will be held from August 20-22 in Ningbo, Zhejiang, focusing on the adaptability of AI in biomanufacturing scenarios, potential gains, and effective application methods [3]. - Key discussions will include the empowerment of synthetic biology through AI, with notable speakers from various institutions and companies addressing critical questions regarding AI's role in biomanufacturing [3][4]. Group 2: Conference Agenda - The conference will feature a macro forum on biomanufacturing, with sessions on AI's role in synthetic biology, authoritative interpretations of AI applications in biomanufacturing, and discussions on technological innovations driving growth [4][5]. - Specific sessions will cover topics such as data-driven programmable protein engineering, online metabolic analysis of E. coli cultivation processes, and the development of life science tools based on micro-nano chips and AI [6][10]. Group 3: Supporting Organizations - The event is organized by Ningbo Detai Zhongyan Information Technology Co., Ltd., with support from various academic and research institutions, including Peking University Ningbo Institute of Ocean Medicine and the China Society of Biotechnology [11][12].

Core Viewpoint - SynBioCon reports that Jiangsu Siweibo Biotechnology Co., Ltd. has successfully signed a multi-million B round investment agreement with Shenzhen Jiadao Green Low-Carbon Investment Fund, which will inject strong momentum into the company's continuous development. Notably, Ant Financial Chairman Jing Xiandong continues to invest in this round, demonstrating confidence in the company's prospects [2][4]. Company Overview - Siweibo is a leading enterprise in the agricultural microbiology sector and is a key laboratory for green intelligent fertilizers under the Ministry of Agriculture and Rural Affairs. The company has established a comprehensive research, production, sales, and service system that includes core technologies such as microbial strain exploration, high-throughput screening, molecular biology research, active gene regulation, metabolite preparation, and customized applications of composite microorganisms [4]. Funding Utilization - The funds from this round of financing will primarily be used for agricultural biotechnology research and development, industrial investment layout, and team building. By increasing R&D investment, Siweibo aims to accelerate the productization and industrialization of core technologies, enhancing its technological advantages and market competitiveness in areas such as microbial fertilizers and agricultural waste resource utilization [4]. Strategic Goals - Siweibo plans to expand its business footprint through industrial investment layout, strengthen cooperation with upstream and downstream enterprises, and improve overall operational efficiency. Enhanced team building will provide talent support for continuous innovation and stable development [4]. Future Outlook - Siweibo intends to leverage the funds and strategic resources obtained from this financing to accelerate technological innovation and product upgrades, providing high-quality products and services to a broader customer base and creating greater value for society. With the growing demand for agricultural green development, Siweibo is expected to play a leading role in the agricultural biotechnology field, driving innovation and development in the industry [4].

Core Viewpoint - The article discusses the construction project of a collagen production line by Shandong Furida Biotechnology Co., Ltd., highlighting its investment, production capacity, and timeline for completion [2]. Summary by Sections Project Progress - Shandong Furida Biotechnology Co., Ltd. is expanding its collagen production line, located in Linyi City, Shandong Province, with a total investment of 12 million yuan, including 500,000 yuan for environmental protection [2]. - The project will utilize existing facilities and is expected to produce 200 kg of collagen annually upon completion in June 2025 [2]. Existing Project Status - The company has several ongoing projects, including: - Sodium hyaluronate project with an annual output of 50 tons [4]. - Various fermentation projects with different production capacities, including: - Recombinant Type II collagen: 115.2 kg/a - Recombinant Type XVII collagen: 64 kg/a - Recombinant Type III transmembrane collagen: 20.8 kg/a - The total annual production capacity for collagen will reach 200 kg [3][4]. Industry Events - The fourth Synthetic Biology and Green Bio-Manufacturing Conference (SynBioCon 2025) will be held from August 20-22, 2025, in Ningbo, Zhejiang Province, focusing on AI and bio-manufacturing, green chemicals, new materials, future food, and agriculture [8][9].

Core Viewpoint - The article highlights the recent project announcements by Heilongjiang Xinhecheng Biotech Co., Ltd., focusing on their expansion in production capacity and the upcoming SynBioCon 2025 conference, which emphasizes advancements in synthetic biology and green manufacturing [2][5]. Group 1: Project Announcements - Heilongjiang Xinhecheng Biotech Co., Ltd. has two new projects: the A9, A10, and functional fermentation products project, and the A18, A20, and isocyanic acid project [3][4]. - The A9, A10 project aims to utilize existing facilities to establish a production capacity of 6,000 tons/year for A9, 5,000 tons/year for A10, and smaller capacities for other products, totaling various outputs [3]. - The A18, A20 project plans to produce 1,000 tons/year of A18, 10,000 tons/year of isocyanic acid, and 3,000 tons/year of A20, with an estimated investment of 83.16 million yuan [4]. Group 2: Financial Performance - Xinhecheng reported impressive financial results with revenues of 21.6 billion yuan and a net profit of 5.869 billion yuan, indicating strong growth in their operations [5]. Group 3: Upcoming Conference - The SynBioCon 2025 conference will take place from August 20-22 in Ningbo, Zhejiang, focusing on AI and synthetic biology, green chemistry, new materials, future food, and agriculture [9][10]. - The conference will feature various activities, including a youth forum, high-level discussions, and a showcase of synthetic biology innovations [9][11].

| 08.22 | 星期五 上午 浙江·宁波东港喜来登酒店 | | --- | --- | | 09:00 | 工信部(第一批)人工智能在生物制造领域典型案例1 | | 09:20 | | | 09:20 | 工信部(第一批)人工智能在生物制造领域典型案例2 | | 09:40 | | | 09:40 | 工信部(第一批)人工智能在生物制造领域典型案例3 | | 10:00 | | | 10:00 | 工信部(第一批)人工智能在生物制造领域典型案例4 | | 10:20 | | | 10:20 | □ 茶歇&展位交流 | | 10:40 | | | 10:40 11:00 | 数据驱动的可编程化蛋白的挖掘与工程化 | | | - | 2025 年 3 月，国家政府工作报告明确提出：培育发展生物制造等未来产业。我们将启动 《 2025 人工智能赋能生物制造产业创新发展蓝皮书》撰写 工作 ，上海市经济和信息化发展研究中心受邀担任 《 蓝皮书 》 指导单位，参与和支持编委团队开展调研。 《蓝皮书》课题组，将于 北京、上海、深圳、苏州、武汉、安徽等城市 ，系统性的开展实地调研和座谈研讨， 系统调研并深度聚焦产业发展需 ...

Core Insights - The article highlights the recent progress of Heilongjiang Xinhecheng in launching multiple fermentation projects, indicating a strategic expansion in biobased energy and materials production [2][3][4]. Group 1: Project Developments - Heilongjiang Xinhecheng is undertaking two major fermentation projects, including the A9, A10, and functional fermentation products project, which aims to establish a production capacity of 5,000 tons/year for A10, 6,000 tons/year for A9, and smaller capacities for other products [3]. - The A18, A20, and isocyanic acid project will utilize existing facilities to produce 1,000 tons/year of A18, 10,000 tons/year of isocyanic acid, and 3,000 tons/year of A20, with an estimated investment of 83.16 million yuan [4]. Group 2: Financial Performance - Heilongjiang Xinhecheng reported impressive financial results, with revenues reaching 21.6 billion yuan and a net profit of 5.869 billion yuan, showcasing significant growth in its operations [5]. Group 3: Industry Events - The SynBioCon 2025 conference will be held from August 20-22 in Ningbo, focusing on synthetic biology and green manufacturing, highlighting the industry's trends and opportunities [9][10][11].

未来食品&农业 | 微元合成 【SynBioCon】 获 悉 ，近日，合成生物学领域的新锐力量—— 芝诺科技 ，成功完成了 数千万元 人民币的Pre-A轮融资 ，在此之前，芝诺科技已经完成了来自中信创投和嘉程资本等知名投资方的 历史 投资。 此次融资将为 芝诺科技 注入强大动力，助力公司在 生产能力提升、管线拓展、团队扩 张以及商业化落地等方面实现跨越性发展。 专题论坛3 来来最品&农业GEN 芝诺科技成立于2020年，是一家专注于合成生物学技术的国家高新技术企业，总部位于北京， 在苏 州、山东东营设有研发中心与百吨级生产基地 。公司核心团队汇聚了来自牛津大学、北京大学等顶 尖机构的跨学科人才，创始人朱天择博士深耕糖化学与代谢流优化十余年，其领衔的技术团队通过 CRISPR 等新一代基因编辑技术，实现工程菌产率较野生型提升千倍以上，生产效率较传统方法提 高十倍。 其关键技术亮点： ▌ 参考信息： 本文部分素材来自公开信息。由作者重新编写，系作者个人观点，本平台发布仅为了传达一种不同观点，不代表 对该观点赞同或支持。如果有任何问题，请联系我们：15356747796（微信同号）。 代谢流精准设计：构建覆盖模式菌 ...